Literature DB >> 23924658

IFN-γ-rich environment programs dendritic cells toward silencing of cytotoxic immune responses.

Urban Svajger1, Natasa Obermajer, Matjaz Jeras.   

Abstract

Lately, there is increasing evidence that emphasizes the regulatory functions of IFN-γ, which serve as negative-feedback mechanisms after, e.g., pathogen clearance, to prevent unnecessary tissue destruction. Inflammatory processes involving Th1 and cytotoxic responses are characterized by high, local IFN-γ concentrations, followed by resolution and immune silencing. Although this is a well-known course of events, extensive attempts to address potential differential effects of IFN-γ in the manner of its availability (quantitatively) in the environment do not exist. We demonstrate that high doses of IFN-γ do not induce DC maturation and activation but instead, induce specific regulatory characteristics in DCs. Considering their phenotype, high doses of IFN-γ extensively induce the expression of ILT-4 and HLA-G inhibitory molecules. Interestingly, the well-known priming effect of IFN-γ for IL-12p70 production is lost at these conditions, and the DC cytokine profile is switched toward an increased IL-10/IL-12p70 ratio upon subsequent stimulation with CD40L. Furthermore, such DCs are capable of silencing cellular immune responses and activation of cytotoxic CD8+ T lymphocytes, resulting in reduced cell proliferation and down-regulation of granzyme B expression. Additionally, we find that in this manner, immune regulation mediated by IFN-γ is not mainly a result of increased enzymatic activity of IDO in DCs but rather, a result of HLA-G signaling, which can be reversed by blocking mAb. Altogether, our results identify a novel mechanism by which a Th1-like environment programs the functional status of DCs to silence ongoing cytotoxic responses to prevent unwanted tissue destruction and inflammation.

Entities:  

Keywords:  homeostasis; immune regulation; inflammation

Mesh:

Substances:

Year:  2013        PMID: 23924658     DOI: 10.1189/jlb.1112589

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model.

Authors:  Rozina Noristani; Sandra Kuehn; Gesa Stute; Sabrina Reinehr; Mathias Stellbogen; H Burkhard Dick; Stephanie C Joachim
Journal:  J Mol Neurosci       Date:  2016-01-08       Impact factor: 3.444

Review 2.  Biological Characteristics of HLA-G and Its Role in Solid Organ Transplantation.

Authors:  Siqi Liu; Nicolaas A Bos; Erik A M Verschuuren; Debbie van Baarle; Johanna Westra
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 3.  Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update.

Authors:  Urban Švajger; Primož Rožman
Journal:  Front Immunol       Date:  2018-10-26       Impact factor: 7.561

Review 4.  Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.

Authors:  Sang Hyun Kim; Ho Hyun Jung; Chong Kil Lee
Journal:  Yonsei Med J       Date:  2018-09       Impact factor: 2.759

5.  CD83+ CCR7+ NK cells induced by interleukin 18 by dendritic cells promote experimental autoimmune uveitis.

Authors:  Qiang Fu; Xuejing Man; Xin Wang; Nannan Song; Yuanbin Li; Jiangnan Xue; Yufei Sun; Wei Lin
Journal:  J Cell Mol Med       Date:  2018-12-08       Impact factor: 5.310

6.  Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.

Authors:  Richard G Everson; Richard M Jin; Xiaoyan Wang; Michael Safaee; Rudi Scharnweber; Dominique N Lisiero; Horacio Soto; Linda M Liau; Robert M Prins
Journal:  J Immunother Cancer       Date:  2014-05-13       Impact factor: 13.751

Review 7.  Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications.

Authors:  Seungbo Yoo; Sang-Jun Ha
Journal:  Immune Netw       Date:  2016-02-25       Impact factor: 6.303

Review 8.  IDO and Kynurenine Metabolites in Peripheral and CNS Disorders.

Authors:  Yi-Shu Huang; Joy Ogbechi; Felix I Clanchy; Richard O Williams; Trevor W Stone
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

9.  Synergistic Effects of Interferon-γ and Vitamin D3 Signaling in Induction of ILT-3highPDL-1high Tolerogenic Dendritic Cells.

Authors:  Urban Švajger; Primož J Rožman
Journal:  Front Immunol       Date:  2019-11-13       Impact factor: 7.561

Review 10.  HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.